InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Benzeno Sharon, Directeur du Développement Commercial. Director active across 1 company, notably Adaptive Biotechnologies Corp. Aggregated, 15 filings have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €716k. Activity tracked since 4 March 2022. The latest transaction was disclosed on 11 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 条申报中的 15 条
BENZENO SHARON is Directeur du Développement Commercial at Adaptive Biotechnologies Corp, where the listed function is Chief Commercial Ofc Imm Med. Across the 15 filings on record, the sampled recent filings run from 2022-03-08 to 2026-06-30, with 0 EUR in buys and 715739 EUR in sells, and the most common transaction nature is Levée d'options.